<?xml version="1.0" encoding="UTF-8"?>
<p id="p0175">Nitazoxanide, a thiazolide class of drugs, is an antiprotozoal agent used for the treatment of various protozoal and helminthic infections 
 <xref rid="b0670" ref-type="bibr">[134]</xref>. Apart from its antiprotozoal potential, nitazoxanide has established itself as a broad-spectrum antiviral agent showing potency against both the DNA and RNA viruses 
 <xref rid="b0675" ref-type="bibr">[135]</xref>. Recently, nitazoxanide was shown to effectively inhibit the SARS-CoV-2 in Vero E6 cells (EC
 <sub>50</sub> = 2.12 µM) 
 <xref rid="b0310" ref-type="bibr">[62]</xref>. Considering its antiviral property along with its anti-inflammatory potential 
 <xref rid="b0680" ref-type="bibr">[136]</xref>, nitazoxanide could act as a possible therapeutic intervention for COVID-19. However, further studies must be conducted to warrant such a claim.
</p>
